Introduction
Ultrasound-guided thoracic paravertebral block (UTPB) is widely used for postoperative analgesia in thoracic surgery. However, it has many disadvantages. Thoracoscopy-guided thoracic paravertebral block (TTPB) is a new technique for thoracic paravertebral block (TPB). In this study, we compared the use of TTPB and UTPB for pain management after thoracoscopic radical surgery for lung cancer.
Methods
In total, 80 patients were randomly divided 1:1 into the UTPB group and the TTPB group. The surgical time of TPB, the success rate of the first puncture, block segment range, visual analog scale (VAS) scores at 2, 6, 12, 24, and 48 h post operation, and the incidence of postoperative adverse reactions were compared between the two groups.
Results
The surgical time of TPB was significantly shorter in the TTPB group than in the UTPB group (2.2 ± 0.3 vs. 5.7 ± 1.7 min,
t
= − 12.411,
P
< 0.001). The success rate of the first puncture and the sensory block segment were significantly higher in the TTPB group than in the UTPB group (100% vs. 76.9%,
χ
2
= 8.309,
P
< 0.001; 6.5 ± 1.2 vs. 5.1 ± 1.3 levels,
t
= − 5.306,
P
< 0.001, respectively). The VAS scores were significantly higher during rest and coughing at 48 h post operation than at 2, 6, 12, and 24 h post operation in the TTPB group. The VAS scores were significantly lower during rest and coughing at 12 and 24 h post operation in the TTPB group than in the UTPB group (rest: 2.5 ± 0.4 vs. 3.4 ± 0.6,
t
= 7.325,
P
< 0.001; 2.5 ± 0.5 vs. 3.5 ± 0.6,
t
= 7.885,
P
< 0.001; coughing: 3.4 ± 0.6 vs. 4.2 ± 0.7,
t
= 5.057,
P
< 0.001; 3.4 ± 0.6 vs. 4.2 ± 0.8,
t
= 4.625,
P
< 0.001, respectively). No significant difference was observed in terms of postoperative adverse reactions between the two groups.
Conclusions
Compared with UTPB, TTPB shows advantages, such as simpler and more convenient surgery, shorter surgical time, a higher success rate of the first puncture, wider block segments, and superior analgesic effect. TTPB can effectively reduce postoperative pain due to thoracoscopic lung cancer radical surgery.
Trial Registration
https://www.chictr.org.cn
, identifier ChiCTR2300072005, prospectively registered on 31/05/2023.